Medicare is wading into dangerous territory here. Instead of further scrutinizing the current conditions on the no-pay list, they’re aggressively expanding it.
Policy makers should be aware of the unintended consequences of certain pay for performance measures.
A poorly thought-out no-pay list will lead to similar circumstances, paradoxically increasing costs and patient harm:
For example, even with the best treatment, blood clots remain relatively common in patients after knee and hip replacements, according to the Society of Hospital Medicine, a national group of hospital-based docs. What’s more, the new rules could add incentives for hospitals to over-use blood thinners in an effort to drive rates down.
Similar Posts:
- Do we really need fancier, more expensive hospital gowns?
- Is emergency department boarding associated with undesirable events?
- How carriers of Staphylococcus aureus do worse in the hospital
KevinMD.com on Facebook
{ 1 comment }
Oh, that’s easy. They’ll simply add anticoagulation-related bleed to the list of “no-pay” conditions.
Comments on this entry are closed.